Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Adjuvant Doxycycline to Enhance Anti-Amyloid Effects: Results from the DUAL (Doxycycline to Upgrade response in AL amyloidosis) Study

Anita D'Souza, MBBS, Kathryn E Flynn, PhD, Binod Dhakal, MBBS, Saurabh Chhabra, MD, Marcelo C Pasquini, MDMS, Parameswaran Hari, MBBS, MD

Blood (2018) 132 (Supplement 1): 1999.

https://doi.org/10.1182/blood-2018-99-114783

Published: 2018

Journal Articles

RNA Polymerase 1 Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Malignancies: Results of a Phase I First in Human Study

Amit Khot, MBBS, MD MRCP, FRCPath, FRACP, Natalie Brajanovski, BSc, Donald P Cameron, BSc, Gretchen Poortinga, PhD, Elaine Sanij, PhD, John Lim, PharmD, John Soong, MD FCAP, Nadine Hein, PhD, Emma Link, DPhil, Richard B Pearson, PhD, Ross Hannan, Grant A. McArthur, MBBS, PhD BSc, FRACP, Simon J. Harrison, MBBS,MRCP,FRCPath,FRACP,PhD

Blood (2017) 130 (Supplement 1): 3835.

https://doi.org/10.1182/blood.V130.Suppl_1.3835.3835

Published: 2017

Journal Articles

Vemurafenib in Advanced Patients with Hairy Cell Leukemia (HCL): Results of the Acsé Phase II Trial

Xavier Troussard, MD, Laure Montané, Mourad Tiab, Carine Chaleteix, MD, Isabelle Grulois, Clothilde Lindet, Delphine Legoupil, Frederic Kohser, Diane Pannier, Frederic Maloisel, Pierre Bories, Céline AIT Oukhatar, Natalie Hoog Labouret, Jean-Yves Blay, MD PhD

Blood (2017) 130 (Supplement 1): 156.

https://doi.org/10.1182/blood.V130.Suppl_1.156.156

Published: 2017

Journal Articles

a Phase I Study of BKM120 (Buparlisib) and Rituximab in Patients with Relapsed or Refractory (R/R) B-Cell Non-Hodgkin's Lymphoma (NHL)

Kami J. Maddocks, MD, Jonathon B. Cohen, MD, Ying Huang, MA, MS, Beth A Christian, MD, Don M Benson, MD PhD, Jeffrey Jones, MD MPH, Christopher Flowers, MD MS, Leonard T. Heffner, MD, Cynthia Jenkins, RN, Jennfer Sexton, MHA, CCRC, Alison Neal, MPH, Melissa Kives, MPH, Kristie A. Blum, MD

Blood (2016) 128 (22): 1776.

https://doi.org/10.1182/blood.V128.22.1776.1776

Published: 2016

Journal Articles

Risk of Non-Melanoma Skin Cancer Following Hematopoietic Cell Transplantation and Voriconazole-Associated Risk

Lawrence F. Kuklinski, BA, Shufeng Li, MS, Margaret R. Karagas, PhD, Bernice Y. Kwong, MD, Wen-Kai Weng, MD PhD

Blood (2016) 128 (22): 2249.

https://doi.org/10.1182/blood.V128.22.2249.2249

Published: 2016

Journal Articles

Thrombotic Microangiopathy (TMA) and Other Severe Systemic Reactions Caused By Quinine-Containing Beverages: Report of a Patient and Review of Published Reports

Jordan M Morton, MD, Evaren E Page, MPH, Nathan W Liles, MD MPH, James N. George, MD

Blood (2015) 126 (23): 4651.

https://doi.org/10.1182/blood.V126.23.4651.4651

Published: 2015

Journal Articles

Diverse Mechanisms of Vemurafenib Resistance in BRAF-Mutant Hairy Cell Leukemia

Jae H Park, MD, Stephen S. Chung, MD, Benjamin Durham, MD PhD, Young Rock Chung, MS, Sasinya Scott, MPH, Bartlomiej Getta, MBBS,, Eunhee Kim, PhD, Alan Saven, MD, Richard M. Stone, MD, Kanti R Rai, MD, Michael R. Grever, MD, Jessica K. Altman, MD, Neal Rosen, MD PhD, Ross L. Levine, MD, Michael Berger, PhD, Martin S Tallman, MD, Omar Abdel-Wahab

Blood (2015) 126 (23): 449.

https://doi.org/10.1182/blood.V126.23.449.449

Published: 2015

Journal Articles

Results of a Phase I-II Study of Fenretinide and Rituximab for Patients with B-Cell Lymphomas

Andrew J. Cowan, MD, Philip Stevenson, M.S., Ted A. Gooley, PhD, Shani L. Frayo, George R. Oliveira, MD, Stephen D. Smith, MD, Damian J. Green, MD, Jennifer E. Roden, John M. Pagel, MD PhD, Brent L Wood, MD PhD, Oliver W Press, MD PhD, Ajay K. Gopal, MD

Blood (2015) 126 (23): 2728.

https://doi.org/10.1182/blood.V126.23.2728.2728

Published: 2015

Journal Articles

Inducing iron deficiency improves erythropoiesis and photosensitivity in congenital erythropoietic porphyria

Daniel N. Egan, Zhantao Yang, John Phillips, Janis L. Abkowitz

Blood (2015) 126 (2): 257–261.

https://doi.org/10.1182/blood-2014-07-584664

Published: 2015

Includes: Supplemental data

Journal Articles

Vemurafenib Has Potent Antitumor Activity in Patients with Relapsed/Refractory BRAF Mutant Hairy Cell Leukemia

Jae H Park, MD, Stephen S. Chung, MD, Young Rock Chung, MS, Helen Won, MS, Eunhee Kim, PhD, Alan Saven, MD, Martha Wadleigh, MD, Richard M. Stone, MD, Jacqueline C. Barrientos, MD, Kanti R. Rai, MD, Michael R. Grever, MD, Jessica K. Altman, MD, Mario E Lacouture, MD, Neal Rosen, MD PhD, Michael Berger, PhD, Ross L Levine, MD, Omar Abdel-Wahab, MD, Martin S. Tallman, MD

Blood (2014) 124 (21): 24.

https://doi.org/10.1182/blood.V124.21.24.24

Published: 2014

Journal Articles

Phase II Trial Of The BRAF Inhibitor, Vemurafenib, In Patients With BRAF Mutant Relapsed Or Refractory Hairy Cell Leukemia

Jae H Park, MD, Stephen S. Chung, MD, Young Rock Chung, MSc, Helen Won, MS, Julie Teruya-Feldstein, MD, Michael Berger, PhD, Talal T Khawaja, BS, Mario E Lacouture, MD, Ross L. Levine, MD, Omar Abdel-Wahab, MD, Martin S Tallman, MD

Blood (2013) 122 (21): 2876.

https://doi.org/10.1182/blood.V122.21.2876.2876

Published: 2013

Journal Articles

Inducing Iron Deficiency Dramatically Improves Erythropoiesis and Photosensitivity In Congenital Erythropoietic Porphyria (CEP)

Daniel N. Egan, MD, Zhantao Yang, MD, John Phillips, PhD, Janis L. Abkowitz, MD

Blood (2013) 122 (21): 3442.

https://doi.org/10.1182/blood.V122.21.3442.3442

Published: 2013

Journal Articles

Adulthood residential ultraviolet radiation, sun sensitivity, dietary vitamin D, and risk of lymphoid malignancies in the California Teachers Study

Ellen T. Chang, Alison J. Canchola, Myles Cockburn, Yani Lu, Sophia S. Wang, Leslie Bernstein, Christina A. Clarke, Pamela L. Horn-Ross

Blood (2011) 118 (6): 1591–1599.

https://doi.org/10.1182/blood-2011-02-336065

Published: 2011

Journal Articles

High Prevalence of Vitamin D Deficiency in Allogeneic Stem Cell Transplant Recipients.

Richard W Joseph, Jr., MD, Krishna V. Komanduri, M.D., R. M Saliba, MD, Amin Alousi, MD, S. Giralt, Gabriela Rondon, Joyce Neumann, Cindy Trevino, APN, Daniel R. Couriel, MD, Richard Champlin, U. Popat

Blood (2008) 112 (11): 2138.

https://doi.org/10.1182/blood.V112.11.2138.2138

Published: 2008

Journal Articles

Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria

S. Alexander Holme, Mark Worwood, Alexander V. Anstey, George H. Elder, Michael N. Badminton

Blood (2007) 110 (12): 4108–4110.

https://doi.org/10.1182/blood-2007-04-088120

Published: 2007

Includes: Supplemental data

Journal Articles

Four Novel Mutations in the Ferrochelatase (FECH) Gene in Patients with Erythropoietic Protoporphyria (EPP).

Elena Di Pierro, PhD, Valentina Brancaleoni, PhD, Valeria Besana, PhD, Sabrina Ausenda, PhD, Melanie Care, MSc, Maria Domenica Cappellini, MD

Blood (2007) 110 (11): 3688.

https://doi.org/10.1182/blood.V110.11.3688.3688

Published: 2007

Journal Articles

Photosensitivity and acute liver injury in myeloproliferative disorder secondary to late-onset protoporphyria caused by deletion of a ferrochelatase gene in hematopoietic cells

Richard G. Goodwin, W. Jonathan Kell, Peter Laidler, C. Colin Long, Sharon D. Whatley, Mark McKinley, Michael N. Badminton, Alan K. Burnett, Geraint T. Williams, George H. Elder

Blood (2006) 107 (1): 60–62.

https://doi.org/10.1182/blood-2004-12-4939

Published: 2006

Journal Articles

Motexafin Gadolinium (MGd) Has Clinical Activity in Relapsed/Refractory Low Grade Lymphomas (LG) and Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL).

Brad S. Kahl, MD, Ranjana Advani, MD, Neil Kay, MD, Izidore S. Lossos, MD, Andrew Evens, DO, Leo Gordon, MD, Richard A. Miller, MD, See-Chun Phan, MD

Blood (2005) 106 (11): 4758.

https://doi.org/10.1182/blood.V106.11.4758.4758

Published: 2005

Journal Articles

Ferrochelatase Mutation Screening by Denaturing High Performance Liquid Chomatography in Idiopathic Acquired Sideroblastic Anemia (Refractory Anemia with Ringed Sideroblasts) and Erythrocytic Protoporphyria.

Kathleen A. Hecksel, BS, Gordon W. Dewald, PhD, David P. Steensma, MD

Blood (2005) 106 (11): 3735.

https://doi.org/10.1182/blood.V106.11.3735.3735

Published: 2005

Journal Articles

“Affenmensch” defect defined

Shigeru Sassa

Blood (2001) 98 (12): 3177.

https://doi.org/10.1182/blood.V98.12.3177

Published: 2001

NARROW

Adjuvant Doxycycline to Enhance Anti-Amyloid Effects: Results from the DUAL (Doxycycline to Upgrade response in AL amyloidosis) Study

RNA Polymerase 1 Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Malignancies: Results of a Phase I First in Human Study

Vemurafenib in Advanced Patients with Hairy Cell Leukemia (HCL): Results of the Acsé Phase II Trial

a Phase I Study of BKM120 (Buparlisib) and Rituximab in Patients with Relapsed or Refractory (R/R) B-Cell Non-Hodgkin's Lymphoma (NHL)

Risk of Non-Melanoma Skin Cancer Following Hematopoietic Cell Transplantation and Voriconazole-Associated Risk

Thrombotic Microangiopathy (TMA) and Other Severe Systemic Reactions Caused By Quinine-Containing Beverages: Report of a Patient and Review of Published Reports

Diverse Mechanisms of Vemurafenib Resistance in BRAF-Mutant Hairy Cell Leukemia

Results of a Phase I-II Study of Fenretinide and Rituximab for Patients with B-Cell Lymphomas

Inducing iron deficiency improves erythropoiesis and photosensitivity in congenital erythropoietic porphyria

Vemurafenib Has Potent Antitumor Activity in Patients with Relapsed/Refractory BRAF Mutant Hairy Cell Leukemia

Phase II Trial Of The BRAF Inhibitor, Vemurafenib, In Patients With BRAF Mutant Relapsed Or Refractory Hairy Cell Leukemia

Inducing Iron Deficiency Dramatically Improves Erythropoiesis and Photosensitivity In Congenital Erythropoietic Porphyria (CEP)

Adulthood residential ultraviolet radiation, sun sensitivity, dietary vitamin D, and risk of lymphoid malignancies in the California Teachers Study

High Prevalence of Vitamin D Deficiency in Allogeneic Stem Cell Transplant Recipients.

Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria

Four Novel Mutations in the Ferrochelatase (FECH) Gene in Patients with Erythropoietic Protoporphyria (EPP).

Photosensitivity and acute liver injury in myeloproliferative disorder secondary to late-onset protoporphyria caused by deletion of a ferrochelatase gene in hematopoietic cells

Motexafin Gadolinium (MGd) Has Clinical Activity in Relapsed/Refractory Low Grade Lymphomas (LG) and Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL).

Ferrochelatase Mutation Screening by Denaturing High Performance Liquid Chomatography in Idiopathic Acquired Sideroblastic Anemia (Refractory Anemia with Ringed Sideroblasts) and Erythrocytic Protoporphyria.

“Affenmensch” defect defined

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only